Stockreport

Design Therapeutics' Friedreich Ataxia Program Shows Potential, RBC Says [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF Design Therapeutics' (DSGN) Friedreich Ataxia program could deliver meaningful clinical benefits and [Read more]